Qiliqiangxin inhibits angiotensin II‐induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin‐6-Reference-Cited by-同舟云学术

Qiliqiangxin inhibits angiotensin II‐induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin‐6

Published:2015-03-06 Issue:5 Volume:19 Page:1114-1121
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Zhou Jingmin¹,Jiang Kun¹²,Ding Xuefeng¹²,Fu Mingqiang¹,Wang Shijun¹,Zhu Lingti¹,He Tao¹²,Wang Jingfeng¹,Sun Aijun¹,Hu Kai¹,Chen Li²,Zou Yunzeng¹,Ge Junbo¹

Affiliation:

1. Department of Cardiology Shanghai Institute of Cardiovascular Diseases Zhongshan Hospital Fudan University Shanghai China

2. North Sichuan Medical College Department of Cardiology The Affiliated Hospital of North Sichuan Medical College Nanchong Sichuan China

Funder

National Basic Research Program of China (973 Program)

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.12512

Reference40 articles.

1. Cardiac myofibroblasts differentiated in 3D culture exhibit distinct changes in collagen I production, processing, and matrix deposition

2. Cardiac fibroblasts: At the heart of myocardial remodeling

3. Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes

4. Qiliqiangxin Improves Cardiac Function in Spontaneously Hypertensive Rats Through the Inhibition of Cardiac Chymase

5. Qiliqiangxin Inhibits the Development of Cardiac Hypertrophy, Remodeling, and Dysfunction During 4 Weeks of Pressure Overload in Mice

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?;European Journal of Heart Failure;2023-11-14

2. Inhibition of Pathological Myofibroblast Differentiation of Valvular Interstitial Cell by Atorvastatin, Olmesartan, and Resveratrol in Experimental Heart Valve Model “Contemporary Model with Rabbit Valve”;2022-09-20

3. Integrating Evidence of the Traditional Chinese Medicine Collateral Disease Theory in Prevention and Treatment of Cardiovascular Continuum;Frontiers in Pharmacology;2022-03-15

4. RAS inhibition in resident fibroblast biology;Cellular Signalling;2021-04

5. Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes;Frontiers in Cardiovascular Medicine;2021-01-28